News
The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.
Barchart on MSN5h
What to Expect From Moderna's Next Quarterly Earnings ReportValued at $13 billion by market cap, Cambridge, Massachusetts-based Moderna, Inc. (MRNA) operates as a clinical-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback